Manuscripts
Showing 1591 manuscripts.
Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy
Citation
Gerhard Theron, Sean Brummel, Lee Fairlie, Mauricio Pinilla, Katie McCarthy, Maxensia Owor, Lameck Chinula, Bonus Makanani, Avy Violari, Dhayendre Moodley, Nahida Chakhtoura, Renee Browning, Risa Hoffman, MG Fowler. Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy. Clinical Infectious Diseases. 2021 Jul 15; 73(2):e312-e320. PMID: 32564058; PMCID: PMC8516506.Year
2021
Journal
Clinical Infectious Diseases
Study
1077BF, 1077FF
Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis
Citation
Paul Krogstad, Pearl Samson, Edward P Acosta, Jack Moye, Ellen Townley, Sarah Bradford, Emily Brown, Kayla Denson, Bobbie Graham, Laura Hovind, Thucuma Sise, Hedy Teppler, Sisinyana Ruth Mathiba, Lee Fairlie, Jana L Winckler, Gretchen Slade, Tammy Meyers, International Maternal Pediatric Adolescent AIDS Clinical Trials Network P1101 Team. Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis. Journal of Pediatric Infectious Disease Society. 2021 Mar 26; PMID: 32448902.Year
2021
Journal
Journal of Pediatric Infectious Disease Society
Study
P1101
Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women with HIV
Citation
Adriana Weinberg, Lisa Aaron, Grace Montepiedra, Timothy R Sterling, Renee Browning, Blandina Mmbaga, Tichaona Vhembo, Shilpa Naik, Enid Kabugho, Gaerolwe Masheto, Savita Pahwa, Jyoti S Mathad, Sylvia M LaCourse, Katie McCarthy, Sarah Bradford, Gerhard Theron, Diane Costello, Bonnie Zimmer, Marie F Pierre, Kamunkhwala Gausi, Paolo Denti, David W Haas, Amita Gupta, IMPAACT P1078 study team. Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women with HIV. Clinical Infectious Diseases. 2021 Nov 02; 73(9):e3555-e3562. PMID: 32720695; PMCID: PMC8563205.Year
2021
Journal
Clinical Infectious Diseases
Study
P1078
Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With Human Immunodeficiency Virus
Citation
Gerhard Theron, Grace Montepiedra, Lisa Aaron, Katie McCarthy, Nahida Chakhtoura, Patrick Jean-Philippe, Bonnie Zimmer, Amy James Loftis, Tsungai Chipato, Teacler Nematadzira, Mandisa Nyati, Carolyne Onyango-Makumbi, Gaerolwe Masheto, James Ngocho, Fuanglada Tongprasert, Sandesh Patil, Dominique Lespinasse, Adriana Weinberg, Amita Gupta, IMPAACT P1078 TB APPRISE Study Team. Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With Human Immunodeficiency Virus. Clinical Infectious Diseases. 2021 Jun 01; 72:784-790. PMID: 32997744; PMCID: PMC8315231.Year
2021
Journal
Clinical Infectious Diseases
Study
P1078
Using a Composite Maternal-Infant Outcome Measure in Tuberculosis-Prevention Studies Among Pregnant Women
Citation
Grace Montepiedra, Soyeon Kim, Adriana Weinberg, Gerhard Theron, Timothy R Sterling, Sylvia M LaCourse, Sarah Bradford, Nahida Chakhtoura, Patrick Jean-Philippe, Scott Evans, Amita Gupta. Using a Composite Maternal-Infant Outcome Measure in Tuberculosis-Prevention Studies Among Pregnant Women. Clinical Infectious Diseases. 2021 Aug 02; 73. PMID: 33146706; PMCID: PMC8326545.Year
2021
Journal
Clinical Infectious Diseases
Study
P1078
Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping
Citation
Kamunkhwala Gausi, Lubbe Wiesner, Jennifer Norman, Carole L Wallis, Carolyne Onyango-Makumbi, Tsungai Chipato, David W Haas, Renee Browning, Nahida Chakhtoura, Grace Montepiedra, Lisa Aaron, Katie McCarthy, Sarah Bradford, Tichaona Vhembo, Lynda Stranix-Chibanda, Gaerolwe R Masheto, Avy Violari, Blandina T Mmbaga, Linda Aurpibul, Ramesh Bhosale, Neetal Nevrekhar, Vanessa Rouzier, Enid Kabugho, Mercy Mutambanengwe, Vongai Chanaiwa, Mandisa Nyati, Tsungai Mhembere, Fuanglada Tongprasert, Anneke Hesseling, Katherine Shin, Bonnie Zimmer, Diane Costello, Patrick Jean-Philippe, Timothy R Sterling, Gerhard Theron, Adriana Weinberg, Amita Gupta, Paolo Denti, IMPAACT P1078 (TB APPRISE) Study Group Team. Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping. Clinical Pharmacology & Therapeutics. 2021 Apr 01; 109(4):1034-1044. PMID: 32909316; PMCID: PMC8048881.Year
2021
Journal
Clinical Pharmacology & Therapeutics
Study
P1078
Safety and Efficacy of 48 and 96 Weeks of Alendronate in Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection and Low Bone Mineral Density for Age
Citation
Jane C Lindsey, Denise L Jacobson, Hans M Spiegel, Catherine M Gordon, Rohan Hazra, George K K Siberry. Safety and Efficacy of 48 and 96 Weeks of Alendronate in Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection and Low Bone Mineral Density for Age. Clinical Infectious Diseases. 2021 Mar 15; 72(6):1059-1063. PMID: 32584996; PMCID: PMC7958836.Year
2021
Journal
Clinical Infectious Diseases
Study
P1076
Brief Report: Impact of ART on Maternal Health After Cessation of Breastfeeding
Citation
Sean S Brummel, Taha E Taha, Konstantia Nadia Angelidou, Friday Saidi, Patience Atuhaire, Dingase Dula, Dhayendre Moodley, Allen Matubu, Gift Chareka, Neetal Nevrekar, Tichaona Vhembo, Lee Fairlie, Gerhard Theron, Pendo Mlay, Kathleen George, Michael Basar, Nahida Chakhtoura, Renee Browning, Mary Glenn Fowler, Judith S Currier, IMPAACT 1077BF/FF PROMISE Study Team. Brief Report: Impact of ART on Maternal Health After Cessation of Breastfeeding. Journal of Acquired Immune Deficiency Syndromes. 2021 Apr 01; 86(4):450-454. PMID: 33273210; PMCID: PMC8143379.Year
2021
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
1077FF, 1077BF
Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV
Citation
Kristina M Brooks, Jeremiah D Momper, Mauricio Pinilla, Alice M Stek, Emily Barr, Adriana Weinberg, Jaime G Deville, Irma L Febo, Mikhaela Cielo, Kathleen George, Kayla Denson, Kittipong Rungruengthanakit, David E Shapiro, Elizabeth Smith, Nahida Chakhtoura, James F Rooney, Richard Haubrich, Rowena Espina, Edmund V Capparelli, Mark Mirochnick, Brookie M Best, IMPAACT P1026s Protocol Team. Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV. AIDS. 2021 Mar 01; 35(3):407-417. PMID: 33252495; PMCID: PMC8238253.Year
2021
Journal
AIDS
Study
P1026S
Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study
Citation
Theodore Ruel, Edmund Capparelli, Camlin Tierney, Bryan Nelson, Anne Coletti, Yvonne Bryson, Mark Cotton, Stephen Spector, Mark Mirochnick, Rebecca LeBlanc, Christina Reding, Bonnie Zimmer, Deborah Persaud, Mutsa Bwakura-Dangarembizi, Kimesh Naidoo, Rohan Hazra, Patrick Jean-Philippe, Ellen Chadwick. Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study. Lancet HIV. 2021 Mar 01; 8(3):e149-e157. PMID: 33242457; PMCID: PMC7933083.Year
2021
Journal
Lancet HIV
Study
P1115